Methotrexate Injection USP 10 mg (Methotrexate (Methotrexate Sodium) SOLUTION) 10 MG

Methotrexate Injection USP 10 MG is a prescription medication used for various therapeutic purposes. This solution is manufactured by Pfizer Canada ULC and is available in a 2 mL pack size.

Strength

10 MG

Pack Size

2ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methotrexate Injection USP 10 MG is commonly used for the treatment of certain types of cancer and autoimmune diseases. It works by interfering with the growth of certain cells in the body. This medication is often prescribed for conditions that require intra-arterial administration. What is Methotrexate used for? It is primarily used for cancer treatment and managing autoimmune disorders.

Side Effects

Common effects of Methotrexate Injection USP 10 MG may include nausea, vomiting, and fatigue. Some individuals may experience mouth sores or hair loss. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Methotrexate Injection USP 10 MG should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be used during pregnancy unless specifically advised by a doctor.

Avoid Interactions

Methotrexate Injection USP 10 MG may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Methotrexate Injection USP 10 MG is used for the treatment of certain types of cancer and autoimmune diseases.

Methotrexate Injection USP 10 MG is typically administered intra-arterially, as prescribed by a healthcare professional.

Common side effects may include nausea, vomiting, fatigue, mouth sores, and hair loss.

Methotrexate Injection USP 10 MG should not be used during pregnancy unless specifically advised by a doctor.

If you experience severe or persistent side effects, it is important to contact your healthcare provider immediately.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.